BPC-157 (Body Protection Compound-157) is a 15–amino acid peptide derived from a protein found in human gastric juice. It is the most requested recovery peptide in our clinic, and also the one with the widest gap between what people expect and what the research supports. Here is the honest version.
What BPC-157 does
The mechanism that best explains its effects is angiogenesis — BPC-157 upregulates VEGF and promotes new blood vessel formation in injured tissue. Tendons, ligaments and cartilage heal slowly precisely because they are poorly vascularized. Improving blood supply to those tissues plausibly speeds repair. It also modulates the nitric oxide system and appears to protect the gut lining.
BPC-157 benefits
1. Tendon and ligament recovery
The strongest area of preclinical evidence. Animal studies show accelerated healing of transected Achilles tendon and injured medial collateral ligament, with improved tensile strength. This is what most of our clients use it for: chronic tendinopathy, tennis elbow, rotator cuff irritation, plantar fasciitis, post-surgical recovery.
2. Gut healing
BPC-157 originates from gastric juice and shows protective effects on the intestinal lining in models of NSAID damage, colitis and ulcer formation. Clients with reflux or IBS-type symptoms often report improvement, and it is frequently paired with glutamine.
3. Muscle repair after strain
Faster functional recovery after crush and strain injury in rodent models, with less fibrotic scar tissue formation.
4. Joint comfort
Reported reductions in joint pain, likely secondary to improved perfusion and reduced local inflammatory signaling rather than direct analgesia.
5. Neuroprotection
Early-stage animal data on nerve regeneration and protection after traumatic injury. Interesting, but nowhere near clinical application.
What the research actually says
Almost all BPC-157 data is preclinical — rats and mice, and largely from a single Croatian research group. There are no large human randomized controlled trials. It is not FDA-approved for any indication, and WADA added it to the prohibited list in 2022, so competitive athletes should not use it.
What that means practically: the safety profile in animal work is unusually clean, the mechanism is plausible, and the clinical reports we see are consistently positive — but anyone telling you it is proven in humans is overselling it. Use it as an adjunct to loading, physical therapy and sleep, not as a replacement for them.
Dosing and administration
Typical protocols run 250–500 mcg once or twice daily by subcutaneous injection for four to eight weeks, then a break. For a localized injury, injecting subcutaneously near the site is common practice on the theory of higher local concentration. Oral capsules exist and are mainly used for gut indications, since the peptide is unusually stable in gastric acid; systemic absorption is poorer.
Reconstituted peptide is refrigerated and typically used within four weeks. Any protocol should come from a licensed provider who has reviewed your history — dosing is not one-size-fits-all.
Side effects
Reported side effects are mild and uncommon: injection-site redness, transient lightheadedness, mild nausea, occasional headache. Because human safety data is limited, we do not use it in pregnancy, while breastfeeding, or in patients with an active malignancy — anything that promotes angiogenesis is theoretically a concern with active tumor tissue.
Frequently asked questions
How long does BPC-157 take to work?
Most clients notice a change in pain and function in two to four weeks, with meaningful structural improvement over six to eight weeks. Gut symptoms often respond faster — sometimes within a week or two.
Is BPC-157 legal?
It is not FDA-approved and cannot be sold as a dietary supplement. It is available through licensed providers and compounding pharmacies for research and prescribed use, and it is banned in sanctioned competition by WADA. Rules vary by jurisdiction and sport — check yours before using it.
BPC-157 vs TB-500: which is better?
They work differently and are often stacked. BPC-157 is more localized and vascular, favored for tendon, ligament and gut. TB-500 acts systemically on cell migration and flexibility, favored for widespread or multi-site injury. For a single stubborn tendon, BPC-157 alone is the usual starting point.
Do you have to inject BPC-157?
Injection gives the most reliable systemic and local exposure. Oral capsules are a reasonable option specifically for gut indications because the peptide survives stomach acid, but they are a weaker choice for a tendon problem.
Can you take BPC-157 long term?
Standard practice is cycling — four to eight weeks on, then a break of equal length. Long-term continuous human safety data does not exist, so continuous use is not something we recommend.
Work with a peptide provider
Our nurse practitioners build and monitor peptide protocols in Boston and ship nationwide. See BPC-157 peptide therapy or the peptide therapy overview.
